Get started
Author

Mouhammed Amir Habra

Observed names: Amir Mouhammed Habra, Habra Mouhammed A, Habra, Mouhammed, Habra, Mouhammed A., Habra, Mouhammed Amir, M A Habra, M. A. Habra, M. Amir Habra, M. Habra, M.A. Habra, Mohammed A. Habra, Mohammed Amir Habra, Mouhammad A. Habra, Mouhammad Amir Habra, Mouhammed A. Habra, Mouhammed A Habra, Mouhammed A. Habbra, Mouhammed A. Habra, Mouhammed A. Mouhammed Amir Habra, Mouhammed Amir Habra2, Mouhammed Habra, Mouhammed A. Habra
ORCID: 0000-0002-4148-9637
Observed ORCID: 0000-0002-4148-9637
OpenAlex ID: A5039846489
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 · Martin Schlumberger, Makoto Tahara, et al. · New England Journal of Medicine · 2,096
PDF
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
2016 · Siyuan Zheng, Andrew D. Cherniack, et al. · Cancer Cell · 657
PDF
Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
2010 · Montserrat Ayala-Ramirez, Lei Feng, et al. · The Journal of Clinical Endocrinology & Metabolism · 428
Parathyroid carcinoma: A 22‐year experience
2004 · Naifa L. Busaidy, Camilo Jimenez, et al. · Head & Neck · 305
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
2013 · Montserrat Ayala-Ramirez, Sina Jasim, et al. · European Journal of Endocrinology · 293
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
2018 · Priyanka C. Iyer, Ramona Dadu, et al. · Journal for ImmunoTherapy of Cancer · 239
PDF
Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas
2012 · Montserrat Ayala-Ramirez, Cecile N. Chougnet, et al. · The Journal of Clinical Endocrinology & Metabolism · 212
Lenvatinib: Role in thyroid cancer and other solid tumors
2015 · Maria E. Cabanillas, Mouhammed Amir Habra · Cancer Treatment Reviews · 208
PDF
Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion
2011 · Shamim Ejaz, Rena Vassilopoulou‐Sellin, et al. · Cancer · 180
Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma
2013 · Camilo Jimenez, Eric Rohren, et al. · Current Oncology Reports · 178
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
2016 · Siyuan Zheng, Andrew D. Cherniack, et al. · Cancer Cell · 164
PDF
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra‐adrenal paragangliomas
2011 · Montserrat Ayala‐Ramirez, Lei Feng, et al. · Cancer · 161
PDF
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
2019 · Mouhammed Amir Habra, Bettzy Stephen, et al. · Journal for ImmunoTherapy of Cancer · 160
PDF
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
2013 · A Naing, P LoRusso, et al. · British Journal of Cancer · 134
PDF
Phase 2 study of pembrolizumab in patients with advanced rare cancers
2020 · Aung Naing, Funda Meric-Bernstam, et al. · Journal for ImmunoTherapy of Cancer · 133
PDF
Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic Paraganglioma
2013 · Montserrat Ayala-Ramirez, J. Lynn Palmer, et al. · The Journal of Clinical Endocrinology & Metabolism · 133
Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience
2014 · Ramona Dadu, Komal Shah, et al. · The Journal of Clinical Endocrinology & Metabolism · 132
PDF
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma
2017 · Priyanka C. Iyer, Ramona Dadu, et al. · Thyroid · 124
The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2
2013 · Sonali Thosani, Montserrat Ayala-Ramirez, et al. · The Journal of Clinical Endocrinology & Metabolism · 122
Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?
2013 · Amanda B. Cooper, Mouhammed Amir Habra, et al. · Surgical Endoscopy · 121
THERAPY OF ENDOCRINE DISEASE: Treatment of malignant pheochromocytoma and paraganglioma
2014 · Eric Baudin, Mouhammed Amir Habra, et al. · European Journal of Endocrinology · 116
Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma
2017 · Alejandro Roman-Gonzalez, Shouhao Zhou, et al. · Annals of Surgery · 112
Treatment‐emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)
2018 · Lori J. Wirth, Makoto Tahara, et al. · Cancer · 104
PDF
A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma
2012 · Mouhammed Amir Habra, Shamim Ejaz, et al. · The Journal of Clinical Endocrinology & Metabolism · 101
PDF
Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib
2014 · Ramona Dadu, Catherine Devine, et al. · The Journal of Clinical Endocrinology & Metabolism · 92
Works count: 251
Citation count: 10,770
H-index: 49
I10-index: 107
Year
Topic
Type